Early research (Phase 1)Active Not RecruitingNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 291
Testing effectiveness (Phase 2)WithdrawnNCT06393751What this trial is testingTesting the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian CancerWho this might be right forPlatinum-Refractory Fallopian Tube CarcinomaPlatinum-Refractory Ovarian CarcinomaPlatinum-Refractory Primary Peritoneal Carcinoma+20 more National Cancer Institute (NCI)
Early research (Phase 1)Active Not RecruitingNCT05691504What this trial is testingTesting the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial CancersWho this might be right forAdvanced Endometrial CarcinomaMetastatic Endometrial CarcinomaMetastatic Fallopian Tube Carcinoma+8 more National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT00352300What this trial is testingCarboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma CancerWho this might be right forFallopian Tube CarcinomaInfectious DisorderNeutropenia+4 more Gynecologic Oncology Group 43
Testing effectiveness (Phase 2)Study completedNCT03648489What this trial is testingDual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)Who this might be right forOvarian CancerOvarian NeoplasmsOvarian Carcinosarcoma+7 more Imperial College London 134
Early research (Phase 1)Ended earlyNCT03924245What this trial is testingOlaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube CancersWho this might be right forFallopian Tube CancerFallopian Tube CarcinosarcomaFallopian Tube Clear Cell Adenocarcinoma+10 more Vanderbilt-Ingram Cancer Center 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT05920798What this trial is testingVaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity CancerWho this might be right forFallopian Tube CarcinosarcomaPrimary Peritoneal CarcinosarcomaRecurrent Fallopian Tube Carcinoma+13 more Mayo Clinic 38
Testing effectiveness (Phase 2)Looking for participantsNCT06639074What this trial is testingFolate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT TrialWho this might be right forAdvanced Fallopian Tube CarcinomaAdvanced Fallopian Tube High Grade Serous AdenocarcinomaAdvanced Ovarian Carcinoma+15 more Mayo Clinic 78
Early research (Phase 1)Looking for participantsNCT06483048What this trial is testingMUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian CancerWho this might be right forPlatinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+13 more Mayo Clinic 12
Testing effectiveness (Phase 2)Study completedNCT01010126What this trial is testingTemsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell CancerWho this might be right forAdult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more National Cancer Institute (NCI) 252
Early research (Phase 1)Study completedNCT02020707What this trial is testingNab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological CancersWho this might be right forCervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more Mayo Clinic 43
Early research (Phase 1)Study completedNCT00989651What this trial is testingCarboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forFallopian Tube CarcinomaFallopian Tube CarcinosarcomaFallopian Tube Clear Cell Adenocarcinoma+35 more National Cancer Institute (NCI) 431
Early research (Phase 1)Study completedNCT00085358What this trial is testingCarboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)Who this might be right forBrenner TumorFallopian Tube CancerOvarian Carcinosarcoma+10 more National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00006981What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced CancerWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT04919629What this trial is testingAPL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant EffusionWho this might be right forFallopian Tube CarcinosarcomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Adenocarcinoma+12 more Roswell Park Cancer Institute 60
Not applicableStudy completedNCT01080521What this trial is testingChanges in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving ChemotherapyWho this might be right forCognitive Side Effects of Cancer TherapyMalignant Ovarian Epithelial TumorOvarian Brenner Tumor+51 more Gynecologic Oncology Group 247
Testing effectiveness (Phase 2)Study completedNCT05494580What this trial is testingPamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian CancerWho this might be right forOvarian CancerOvarian CarcinomaPlatinum-resistant Ovarian Cancer+2 more Sun Yat-sen University 29
Large-scale testing (Phase 3)UnknownNCT00954174What this trial is testingPaclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity CancerWho this might be right forMixed Mesodermal (Mullerian) TumorOvarian CarcinosarcomaRecurrent Fallopian Tube Carcinoma+39 more GOG Foundation 637
Early research (Phase 1)Study completedNCT03552471What this trial is testingMirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal CancerWho this might be right forBRCA1 Gene MutationBRCA2 Gene MutationFolate Receptor Alpha Positive+7 more Ohio State University Comprehensive Cancer Center 25
Early research (Phase 1)Study completedNCT00066651What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced Solid TumorsWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)